Teva Launches First Inhalable Antipsychotic Drug in U.S.

Adasuve reduces agitation in adults with schizophrenia or bipolar I disorder.

Yoram Gabison
Haaretz
Send in e-mailSend in e-mail
Yoram Gabison
Haaretz

Comments